You are viewing the site in preview mode

Skip to main content

Table 4 The relationship between the use of psychotropic drugs and the scores of the scales in patient and control groups

From: Evaluation of the effect of the COVID-19 pandemic on depression, anxiety and psychological resilience in patients with primary immunodeficiency

  

Pscychotropic drug use

 

No

Yes

p value

HAM-D

Patient group

4(0–20)

9.5(0–21)

0.009

Control group

2(0–16)

6(0–15)

0.001

HAM-A

Patient group

5(0–21)

10.5(0–15)

0.017

Control group

2(0–20)

6(0–19)

0.062

RSA

Patient group

122.4 ± 19.2

122.6 ± 20.9

0.976

Control group

136.6 ± 16.2

134.1 ± 13.1

0.572

PRPS

Patient group

32.3 ± 6.9

37.5 ± 3.9

< 0.001

Control group

27.8 ± 7.1

29.8 ± 8.2

0.358

  1. Bold values indicate statistically significant differences (p < 0.05)
  2. HAM-D Hamilton Depression Rating Scale, HAM-A Hamilton Anxiety Rating Scale, RSA Resilience Scale For Adults, PRPS Pandemic Risk Perception Scale
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us